日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

L-Type Ca(v)1.3 and HCN Channels Mediate Heart Rate Acceleration by Catecholamines

L型Ca(v)1.3和HCN通道介导儿茶酚胺引起的心率加快

Torre, Eleonora; Faure, Mélanie; Bidaud, Isabelle; Baudot, Matthias; Gaillardon, Marvin; Pereira de Vasconcelos, Walma; Laarioui, Sihame; Talssi, Leïla; Engeland, Birgit; Reiken, Steven; Saponaro, Andrea; Chen, Bi-Xing; Moroni, Anna; D'Souza, Alicia; Isbrandt, Dirk; Marks, Andrew R; Marx, Steven O; Mesirca, Pietro; Mangoni, Matteo E

Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation

辛伐他汀诱导的骨骼肌无力的结构基础与1型兰尼碱受体T4709M突变相关

Weninger, Gunnar; Dridi, Haikel; Reiken, Steven; Yuan, Qi; Zhao, Nan; Groom, Linda; Leigh, Jennifer; Liu, Yang; Tchagou, Carl; Kang, Jiayi; Chang, Alexander; Luna-Figueroa, Estefania; Miotto, Marco C; Wronska, Anetta; Dirksen, Robert T; Marks, Andrew R

RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data

RYR2 变异体在儿茶酚胺敏感性多形性室性心动过速患者中的研究:来自蛋白质结构和临床数据的启示

Chang, Alexander; Beqaj, Halil; Sittenfeld, Leah; Miotto, Marco C; Dridi, Haikel; Willson, Gloria; Martinez Jorge, Carolyn; Altosaar Li, Jaan; Reiken, Steven; Liu, Yang; Dai, Zonglin; Tchagou, Carl; Elsayed, Sana; Marx, Steven O; Marks, Andrew R

Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders

利用别嘌醇和黄嘌呤衍生物靶向兰尼碱受体治疗心脏和肌肉骨骼无力疾病

Miotto, Marco C; Luna-Figueroa, Estefania; Tchagou, Carl; Bahlouli, Laith; Reiken, Steven; Dridi, Haikel; Liu, Yang; Weninger, Gunnar; Marks, Andrew R

Atrial fibrillation-induced neurocognitive and vascular dysfunction is averted by mitochondrial oxidative stress reduction

降低线粒体氧化应激可预防心房颤动引起的神经认知和血管功能障碍。

Guttipatti, Pavithran; Ji, Ruiping; Saadallah, Najla; Avula, Uma Mahesh R; Sonmez, Deniz Z; Fang, Albert; Li, Eric; Desai, Amar D; Parsons, Samantha; Dasrat, Parmanand; Sison, Christine; Sun, Yanping; Goulbourne, Chris N; Reiken, Steven R; Wan, Elaine Y

Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel

针对 RyR1 相关肌病的通用型 Prime 编辑治疗策略:一种保护性突变可挽救 RyR1 通道的渗漏

Godbout, Kelly; Dugas, Mathieu; Reiken, Steven R; Ramezani, Sina; Falle, Alexia; Rousseau, Joël; Wronska, Anetta E; Lamothe, Gabriel; Canet, Geoffrey; Lu, Yaoyao; Planel, Emmanuel; Marks, Andrew R; Tremblay, Jacques P

Probing the Ca(V)1.2 interactome in heart failure identifies a positive modulator of inotropy and lusitropy.

探究心力衰竭中的 Ca(V)1.2 相互作用组,发现了一种正向调节肌力和舒张功能的调节因子

Rodriques Aaron, Liu Guoxia, Katchman Alex, Zakharov Sergey, Wan Elaine, Kalocsay Marian, Eisert Robyn, Bradshaw Gary A, Chen Bi-Xing, Yang Lin, Reiken Steven, Lai Xianghai, Ji Ruiping, Saadallah Najla, Topkara Veli, Fanourakis Stavros, Yuan Qi, Kushner Jared

Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders

心力衰竭和心律失常性疾病中 2 型瑞诺丁受体漏出的结构基础

Marco C Miotto, Steven Reiken, Anetta Wronska, Qi Yuan, Haikel Dridi, Yang Liu, Gunnar Weninger, Carl Tchagou, Andrew R Marks

Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy

瑞安诺丁受体功能障碍导致杜氏扩张型心肌病衰老和纤维化

Monia Souidi, Jessica Resta, Haikel Dridi, Yvonne Sleiman, Steve Reiken, Karina Formoso, Sarah Colombani, Pascal Amédro, Pierre Meyer, Azzouz Charrabi, Marie Vincenti, Yang Liu, Rajesh Kumar Soni, Frank Lezoualc'h, D V M Stéphane Blot, François Rivier, Olivier Cazorla, Angelo Parini, Andrew R Marks,

Consensus Statement on the Outcome of the European Herbal Health Products Summit - Which Way Forward?

欧洲草药保健产品峰会成果共识声明——前进的方向是什么?

Heinrich, Michael; Reiken, Babette; Roether, Bernd; Müller, Angela; Rumsch, Julia; Symma, Nico